UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.08B |
| 2 |
UBS Group
UBS
|
+$643M |
| 3 |
Southwest Airlines
LUV
|
+$588M |
| 4 |
Medtronic
MDT
|
+$505M |
| 5 |
Workday
WDAY
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.51B |
| 2 |
Tesla
TSLA
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$976M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$803M |
| 5 |
Chevron
CVX
|
+$688M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.79% |
| 2 | Financials | 9.18% |
| 3 | Industrials | 6.66% |
| 4 | Consumer Discretionary | 6.42% |
| 5 | Healthcare | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5826
PUT
BioMarin Pharmaceuticals
BMRN
$13B
| $704K | ﹤0.01% |
13,000
-1,000
| -7% | -$57.2K |
|
|
PEO
5827
Adams Natural Resources Fund
PEO
$779M
| $702K | ﹤0.01% |
32,605
-4,680
| -13% | -$101K |
|
|
HGLB
5828
Highland Global Allocation Fund
HGLB
$179M
| $700K | ﹤0.01% |
77,005
-4,416
| -5% | -$37.8K |
|
5829
CALL
Eagle Materials
EXP
$6.4B
| $699K | ﹤0.01% |
+3,000
| New | +$680K |
|
5830
OptimizeRx
OPRX
$164M
| $699K | ﹤0.01% |
34,086
-68,565
| -67% | -$1.09M |
|
5831
CALL
Johnson Controls International
JCI
$93.1B
| $698K | ﹤0.01% |
6,350
-43,650
| -87% | -$4.66M |
|
5832
ProShares S&P 500 High Income ETF
ISPY
$1.27B
| $696K | ﹤0.01% |
15,438
+8,395
| +119% | +$366K |
|
5833
Invesco Dorsey Wright Financial Momentum ETF
PFI
$60.6M
| $696K | ﹤0.01% |
12,001
+161
| +1% | +$9.12K |
|
|
CRON
5834
Cronos Group
CRON
$1.16B
| $695K | ﹤0.01% |
250,141
-42,710
| -15% | -$101K |
|
|
MVT
5835
DELISTED
BlackRock MuniVest Fund II
MVT
| $695K | ﹤0.01% |
65,381
+26,731
| +69% | +$276K |
|
5836
Compass Therapeutics
CMPX
$405M
| $694K | ﹤0.01% |
198,271
-65,255
| -25% | -$206K |
|
|
DFDV
5837
DeFi Development Corp
DFDV
$92.5M
| $693K | ﹤0.01% |
49,810
+2,420
| +5% | +$40.2K |
|
5838
ProShares S&P Technology Dividend Aristocrats ETF
TDV
$281M
| $692K | ﹤0.01% |
8,004
-9,703
| -55% | -$820K |
|
5839
Pennant Group
PNTG
$1.37B
| $690K | ﹤0.01% |
27,351
-57,535
| -68% | -$1.41M |
|
|
ALMU
5840
Aeluma Inc
ALMU
$337M
| $688K | ﹤0.01% |
42,727
-9,143
| -18% | -$171K |
|
|
SVCO
5841
Silvaco Group
SVCO
$246M
| $687K | ﹤0.01% |
126,942
-9,656
| -7% | -$47.1K |
|
5842
Inovio Pharmaceuticals
INO
$113M
| $686K | ﹤0.01% |
293,062
+93,383
| +47% | +$179K |
|
|
LAND
5843
Gladstone Land Corp
LAND
$358M
| $685K | ﹤0.01% |
74,799
-9,489
| -11% | -$89.7K |
|
|
GDEN
5844
DELISTED
Golden Entertainment
GDEN
| $685K | ﹤0.01% |
29,051
-4,101
| -12% | -$109K |
|
|
TEAF
5845
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
| $684K | ﹤0.01% |
58,190
-50,074
| -46% | -$603K |
|
|
PGP
5846
PIMCO Global StockPLUS & Income Fund
PGP
$103M
| $684K | ﹤0.01% |
80,000
| – | – |
|
5847
Lifecore Biomedical
LFCR
$179M
| $683K | ﹤0.01% |
92,828
-3,823
| -4% | -$28.9K |
|
5848
Kovitz Core Equity ETF
EQTY
$1.47B
| $683K | ﹤0.01% |
26,615
-43,057
| -62% | -$1.1M |
|
5849
Alector
ALEC
$219M
| $682K | ﹤0.01% |
230,499
+188,606
| +450% | +$416K |
|
5850
CALL
eBay
EBAY
$45.9B
| $682K | ﹤0.01% |
+7,500
| New | +$663K |
|
Similar funds
UBS Group's Q3 2025 Portfolio in Review
As of Q3 2025, UBS Group held 11,340 positions worth $638B, up 11% from $578B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group's Q3 2025 filing shows 1,170 new, 4,190 increased, 4,486 reduced and 1,079 closed positions. Its largest new stake was Paramount Skydance Corp: 13,287,677 shares worth $251M. The largest sale was NVIDIA, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.
- UBS Group's largest Q3 2025 buy was Paramount Skydance Corp: 13,287,677 shares worth $251M.
- UBS Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $1.08B increase.
- UBS Group's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $1.51B.
- UBS Group fully exited Hess in Q3 2025, selling an estimated $442M.
- UBS Group's ten largest holdings make up 16% of its $638B portfolio in Q3 2025.
- UBS Group opened 1,170 new positions and closed 1,079 in Q3 2025.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $638B.
Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.